Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
Prognostic models are generally used to predict gastric cancer outcomes. However, no model combining patient-, tumor- and host-related factors has been established to predict outcomes after radical gastrectomy, especially outcomes of patients without nodal involvement. The aim of this study was to d...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4468084?pdf=render |
id |
doaj-cbc2227c56b44d379cb9c2afffb487d7 |
---|---|
record_format |
Article |
spelling |
doaj-cbc2227c56b44d379cb9c2afffb487d72020-11-24T22:07:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01106e012854010.1371/journal.pone.0128540Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.Jing-lei QuXiu-juan QuZhi LiJing-dong ZhangJing LiuYue-e TengBo JinMing-fang ZhaoPing YuJing ShiLing-Yu FuZhen-ning WangYun-peng LiuPrognostic models are generally used to predict gastric cancer outcomes. However, no model combining patient-, tumor- and host-related factors has been established to predict outcomes after radical gastrectomy, especially outcomes of patients without nodal involvement. The aim of this study was to develop a prognostic model based on the systemic inflammatory response and clinicopathological factors of resectable gastric cancer and determine whether the model can improve prognostic accuracy in node-negative patients. We reviewed the clinical, laboratory, histopathological and survival data of 1397 patients who underwent radical gastrectomy between 2007 and 2013. Patients were split into development and validation sets of 1123 and 274 patients, respectively. Among all 1397 patients, 545 had node-negative gastric cancer; 440 were included in the development set, 105 were included in the validation set. A prognostic model was constructed from the development set. The scoring system was based on hazard ratios in a Cox proportional hazard model. In the multivariate analysis, age, tumor size, Lauren type, depth of invasion, lymph node metastasis, and the neutrophil--lymphocyte ratio were independent prognostic indicators of overall survival. A prognostic model was then established based on the significant factors. Patients were categorized into five groups according to their scores. The 3-year survival rates for the low- to high-risk groups were 98.9%, 92.8%, 82.4%, 58.4%, and 36.9%, respectively (P < 0.001). The prognostic model clearly discriminated patients with stage pT1-4N0M0 tumor into four risk groups with significant differences in the 3-year survival rates (P < 0.001). Compared with the pathological T stage, the model improved the predictive accuracy of the 3-year survival rate by 5% for node-negative patients. The prognostic scores also stratified the patients with stage pT4aN0M0 tumor into significantly different risk groups (P = 0.004). Furthermore, the predictive value of this model was validated in an independent set of 274 patients. This model, which included the systemic inflammatory markers and clinicopathological factors, is more effective in predicting the prognosis of node-negative gastric cancer than traditional staging systems. Patients in the high-risk group might be good candidates for adjuvant chemotherapy.http://europepmc.org/articles/PMC4468084?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jing-lei Qu Xiu-juan Qu Zhi Li Jing-dong Zhang Jing Liu Yue-e Teng Bo Jin Ming-fang Zhao Ping Yu Jing Shi Ling-Yu Fu Zhen-ning Wang Yun-peng Liu |
spellingShingle |
Jing-lei Qu Xiu-juan Qu Zhi Li Jing-dong Zhang Jing Liu Yue-e Teng Bo Jin Ming-fang Zhao Ping Yu Jing Shi Ling-Yu Fu Zhen-ning Wang Yun-peng Liu Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer. PLoS ONE |
author_facet |
Jing-lei Qu Xiu-juan Qu Zhi Li Jing-dong Zhang Jing Liu Yue-e Teng Bo Jin Ming-fang Zhao Ping Yu Jing Shi Ling-Yu Fu Zhen-ning Wang Yun-peng Liu |
author_sort |
Jing-lei Qu |
title |
Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer. |
title_short |
Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer. |
title_full |
Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer. |
title_fullStr |
Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer. |
title_full_unstemmed |
Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer. |
title_sort |
prognostic model based on systemic inflammatory response and clinicopathological factors to predict outcome of patients with node-negative gastric cancer. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
Prognostic models are generally used to predict gastric cancer outcomes. However, no model combining patient-, tumor- and host-related factors has been established to predict outcomes after radical gastrectomy, especially outcomes of patients without nodal involvement. The aim of this study was to develop a prognostic model based on the systemic inflammatory response and clinicopathological factors of resectable gastric cancer and determine whether the model can improve prognostic accuracy in node-negative patients. We reviewed the clinical, laboratory, histopathological and survival data of 1397 patients who underwent radical gastrectomy between 2007 and 2013. Patients were split into development and validation sets of 1123 and 274 patients, respectively. Among all 1397 patients, 545 had node-negative gastric cancer; 440 were included in the development set, 105 were included in the validation set. A prognostic model was constructed from the development set. The scoring system was based on hazard ratios in a Cox proportional hazard model. In the multivariate analysis, age, tumor size, Lauren type, depth of invasion, lymph node metastasis, and the neutrophil--lymphocyte ratio were independent prognostic indicators of overall survival. A prognostic model was then established based on the significant factors. Patients were categorized into five groups according to their scores. The 3-year survival rates for the low- to high-risk groups were 98.9%, 92.8%, 82.4%, 58.4%, and 36.9%, respectively (P < 0.001). The prognostic model clearly discriminated patients with stage pT1-4N0M0 tumor into four risk groups with significant differences in the 3-year survival rates (P < 0.001). Compared with the pathological T stage, the model improved the predictive accuracy of the 3-year survival rate by 5% for node-negative patients. The prognostic scores also stratified the patients with stage pT4aN0M0 tumor into significantly different risk groups (P = 0.004). Furthermore, the predictive value of this model was validated in an independent set of 274 patients. This model, which included the systemic inflammatory markers and clinicopathological factors, is more effective in predicting the prognosis of node-negative gastric cancer than traditional staging systems. Patients in the high-risk group might be good candidates for adjuvant chemotherapy. |
url |
http://europepmc.org/articles/PMC4468084?pdf=render |
work_keys_str_mv |
AT jingleiqu prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT xiujuanqu prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT zhili prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT jingdongzhang prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT jingliu prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT yueeteng prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT bojin prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT mingfangzhao prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT pingyu prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT jingshi prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT lingyufu prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT zhenningwang prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer AT yunpengliu prognosticmodelbasedonsystemicinflammatoryresponseandclinicopathologicalfactorstopredictoutcomeofpatientswithnodenegativegastriccancer |
_version_ |
1725818450056577024 |